Impact of pneumococcal vaccination on morbidity and mortality of geriatric patients: A case-controlled study

Gerontology

Volumn 49, Issue 4, 2003, Pages 246-250

  Wagner, Christian ^a,e   Popp, Wolfgang ^a   Posch, Martin ^b   Vlasich, Clemens ^c   Rosenberger Spitzy, Angelika ^d  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Aventis Pasteur   (Austria)

^d Geriatriezentrum am Wienerwald   (Austria)

^e 11 Med Abt Lungenkrankheiten/A   (Austria)

Author keywords

Elderly, vaccination; Pneumococcal vaccination; Pneumonia

Indexed keywords

PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

AGED; ARTICLE; AUSTRIA; CASE CONTROL STUDY; CHRONIC DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENDER; GERIATRIC PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VACCINATION;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; HUMANS; INCIDENCE; MORBIDITY; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA;

EID: 0037942563     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070405     Document Type: Article

References (13)

1. Fedson DS: Pneumococcal vaccination: Four issues for Western Europe. Biologicals 1997;25:215-219.
2. Butler JC, Schuchat A: Epidemiology of pneumococcal infections in the elderly. Drugs Aging 1999;15(suppl 1):11-19.
3. Fedson DS, Scott JA, Scott G: The burden of pneumococcal disease among adults in developed and developing countries: What is and is not known. Vaccine 1999;17(suppl 1):11-18.
4. Fedson DS, Musher DM: Pneumococcal vaccine; in Plotkin SA, Mortimer EA, Jr (eds): Vaccine, ed 2. Philadelphia, Saunders, 1994, pp 517-564.
5. Fine M, Orloff JJ, Rihs JD, Vickers RM, Kominos S, Kapoor WN, Arena VC, Yu VL: Evaluation of housestaff physicians' preparation and interpretation of sputum Gram Stains for community-acquired pneumonia. J Gen Intern Med 1991;6:189-198.
6. Fedson DS: Pneumococcal vaccination for older adults: The first 20 years. Drugs Aging 1999;15(suppl 1):21-30.
7. Fine MJ, Smith MA, Carson CA: Efficacy of pneumococcal vaccination in adults: A meta-analysis of randomized controlled trials. Arch Intern Med 1994;154:2666-2677.
8. Vlasich C: Pneumococcal infection and vaccination in the elderly. Vaccine 2001;19:2233-2237.
9. Fedson DS: Pneumococcal vaccination in the United States and 20 other developed countries 1981-1996. Clin Infect Dis 1998;26:117-123.
10. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham JD: Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995;15:369-390.
11. Centers for Disease Control and Prevention: Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices. MMWR 1997;46(RR-8):1-24.
12. Fedson DS: The clinical effectiveness of pneumococcal vaccination: A brief review. Vaccine 1999;17:585-590.
13. Nichol KL, Baken L, Wuorenma J, Nelson A: The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999;159:2437-2442.